Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603012.pdf
Reference29 articles.
1. Abeler VM, Kjorstad KE (1991) Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases. Gynecol Oncol 40: 207–217
2. Abeler VM, Vergote IB, Kjorstad KE, Trope CG (1996) Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 78: 1740–1747
3. Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR (2002) Is there a difference in outcome between stage I–II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? Int J Radiat Oncol Biol Phys 54: 79–85
4. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10–17
5. Boruta II DM, Gehrig PA, Groben PA, Bae-Jump V, Boggess JF, Fowler Jr WC, Van Le L (2004) Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference? Cancer 101: 2214–2221
Cited by 550 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium;Gynecologic Oncology;2024-11
2. Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells;Journal of Cancer Research and Clinical Oncology;2024-08-28
3. Translating biological insights into improved management of endometrial cancer;Nature Reviews Clinical Oncology;2024-08-28
4. Identification of novel biomarkers and potential molecular targets for uterine cancer using network-based approach;Pathology - Research and Practice;2024-08
5. Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma;Modern Pathology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3